OxiWear Inc

OxiWear Inc manufactures FDA-cleared wearable pulse oximetry devices designed for continuous, real-time monitoring of blood oxygen saturation and pulse rate. The company's flagship product is an ear-worn oximeter that delivers medical-grade accuracy during rest and physical activity, with particular advancement in consistent performance across diverse skin tones. The device provides second-by-second measurements via patented technology and integrates wireless connectivity for data sharing with clinicians through mobile apps, text alerts, and vibration notifications when oxygen levels fall below user-defined thresholds. OxiWear targets patients with chronic respiratory and cardiac conditions including pulmonary hypertension, COPD, cystic fibrosis, and pulmonary fibrosis, as well as athletes and individuals requiring supplemental oxygen therapy. The company positions its solution as an alternative to traditional finger-based pulse oximeters, addressing limitations in comfort, mobility, and accuracy—particularly for patients with darker skin pigmentation or conditions like Raynaud's syndrome that compromise finger-based readings. Clinical endorsements from leading institutions (Johns Hopkins Pulmonary Hypertension Program) and patient testimonials emphasize enhanced independence and real-time safety monitoring. OxiWear has received FDA clearance as a medical device and is supported by major health organizations including the American Heart Association, Pulmonary Hypertension Association, COPD Foundation, and Cystic Fibrosis Foundation.